Skip to main content
. 2020 Sep 1;24(5):385–394. doi: 10.4196/kjpp.2020.24.5.385

Fig. 4. Eupatilin reduced plasma MDA and improved antioxidant status in the ALD model.

Fig. 4

The activities of (A) MDA and (B) SOD and the level of (C) GSH were measured in rat plasma (n = 7). Control group: saline + 0.1% CMC-Na, vehicle group: 7 g/kg ethanol + 0.1% CMC-Na, silymarin (positive control) group: 7 g/kg ethanol + silymarin 10 mg/kg, eupatilin 10 mg/kg: 7 g/kg ethanol + eupatilin 10 mg/kg, eupatilin 30 mg/kg: 7 g/kg ethanol + eupatilin 30 mg/kg, and eupatilin 100 mg/kg: 7 g/kg ethanol + eupatilin 100 mg/kg. Data are expressed as mean ± standard error of the mean. CMC-Na, sodium carboxymethyl cellulose; ALD, alcoholic liver disease; MDA, malondialdehyde; SOD, superoxide dismutase; GSH, glutathione. #p < 0.05, ##p < 0.01 vs. the control group, *p < 0.05, **p < 0.01 vs. the vehicle group.